Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01427166 · ClinicalTrials.gov registry record · NA

Non-Invasive Imaging for Cording in Breast Cancer Patients

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT01427166: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01427166 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01427166, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

To date, the scientific literature has yet to provide sufficient evidence regarding the pathophysiology of cording. The objective of this protocol is to evaluate the utility of non invasive vascular imaging for assessing the pathophysiology of cording in a small study cohort of patients who were treated for breast cancer. The hypothesis is that cording may have a vascular etiology

Interventions

  • OTHER Non invasive venous ultrasound

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2011-08
Est. Completion 2012-08
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01427166

The ClinicalTrials.gov registry entry for NCT01427166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Non invasive venous ultrasound is the first listed.

NCT01427166 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01427166 about?

NCT01427166 is a clinical study titled "Non-Invasive Imaging for Cording in Breast Cancer Patients". To date, the scientific literature has yet to provide sufficient evidence regarding the pathophysiology of cording. The objective of this protocol is to evaluate the utility of non invasive vascular imaging for assessing the pathophysiology of cording in a small study cohort of patients who were tre...

What is the current status of trial NCT01427166?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-08. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01427166?

The interventions under investigation include: Non invasive venous ultrasound (OTHER).

Who is sponsoring clinical trial NCT01427166?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.